Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.990
+0.100 (3.46%)
Nov 4, 2024, 4:00 PM EST - Market closed
BDTX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 169 | 145 | 65 | 193 | 1,154 | - | |
Market Cap Growth | 0.77% | 121.66% | -66.10% | -83.26% | - | - | |
Enterprise Value | 70 | 27 | -50 | -13 | 829 | - | |
Last Close Price | 2.99 | 2.81 | 1.80 | 5.33 | 32.05 | - | |
PE Ratio | - | -1.50 | -0.72 | -1.54 | -15.63 | - | |
PB Ratio | 1.52 | 1.24 | 0.57 | 0.99 | 3.75 | - | |
P/FCF Ratio | -3.84 | -2.17 | -0.77 | -1.88 | -22.06 | - | |
P/OCF Ratio | -3.84 | -2.17 | -0.77 | -1.93 | -22.12 | - | |
EV/EBITDA Ratio | -1.97 | -0.31 | 0.54 | 0.10 | -11.93 | - | |
EV/EBIT Ratio | -1.97 | -0.31 | 0.54 | 0.10 | -11.92 | - | |
EV/FCF Ratio | -2.51 | -0.40 | 0.59 | 0.13 | -15.86 | - | |
Debt / Equity Ratio | 0.21 | 0.22 | 0.24 | 0.15 | 0.03 | - | |
Debt / FCF Ratio | -0.35 | -0.38 | -0.33 | -0.28 | -0.17 | - | |
Quick Ratio | 6.67 | 6.69 | 8.05 | 8.87 | 22.16 | 31.80 | |
Current Ratio | 6.87 | 6.82 | 8.37 | 9.12 | 22.48 | 32.02 | |
Return on Equity (ROE) | -83.38% | -70.94% | -58.52% | -49.87% | -29.17% | -35.50% | |
Return on Assets (ROA) | -40.41% | -34.33% | -28.73% | -27.47% | -17.82% | -17.45% | |
Return on Capital (ROIC) | -44.74% | -37.81% | -31.51% | -29.32% | -18.51% | -18.46% | |
Earnings Yield | -47.68% | -56.82% | -139.28% | -65.04% | -5.83% | - | |
FCF Yield | -40.41% | -46.00% | -130.27% | -53.27% | -4.53% | - | |
Buyback Yield / Dilution | -43.95% | -21.00% | -0.38% | -9.97% | -1485.31% | -2.83% | |
Total Shareholder Return | -43.95% | -21.00% | -0.38% | -9.97% | -1485.31% | -2.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.